Joseph Zabinski | VP, Head of Commercial Strategy & AI
OM1

Joseph Zabinski, PhD, MEM is VP, Head of Commercial Strategy & AI at OM1. He oversees design, implementation, and evolution of OM1's commercial strategy, including prioritization, go-to-market planning, and alignment with emergent market needs. Dr. Zabinski also serves as subject matter expert and thought leader for OM1's AI work, including applications of the PhenOM digital phenotyping platform with life science and healthcare provider partners. Prior to joining OM1, Dr. Zabinski was a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Co. He specialized in advising life science and healthcare clients on using AI and advanced analytics, including identification of unmet medical needs, portfolio optimization, and AI strategy. His academic research focused on applications of Bayesian network modeling methods to predicting and stratifying environmental human health risk. Dr. Zabinski holds a master’s degree in engineering management from Dartmouth College, and a doctorate with a focus in health analytics from the School of Public Health at the University of North Carolina, Chapel Hill. He is a 2023 Healthcare Innovation 40 Under 40 Winner.